Journal of Pharmaceutical Investigation

Papers
(The TQCC of Journal of Pharmaceutical Investigation is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Microneedle for transdermal drug delivery: current trends and fabrication185
Nanomedicine-based commercial formulations: current developments and future prospects74
Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors55
Characterization studies of novel series of cobalt (II), nickel (II) and copper (II) complexes: DNA binding and antibacterial activity53
Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: reviewing two decades of research48
Fabrication of aerosol-based nanoparticles and their applications in biomedical fields40
Smart pH-responsive nanomedicines for disease therapy39
Recent trends of self-emulsifying drug delivery system for enhancing the oral bioavailability of poorly water-soluble drugs35
Nanomedicine-based antimicrobial peptide delivery for bacterial infections: recent advances and future prospects33
Development of clindamycin-loaded alginate/pectin/hyaluronic acid composite hydrogel film for the treatment of MRSA-infected wounds31
Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches30
Recent progress in hydrophobic ion-pairing and lipid-based drug delivery systems for enhanced oral delivery of biopharmaceuticals28
Intestinal membrane transporter-mediated approaches to improve oral drug delivery27
Recent progress in cancer immunotherapy approaches based on nanoparticle delivery devices26
Recent advancements in lipid–mRNA nanoparticles as a treatment option for cancer immunotherapy25
Lipid-based nanoparticles for photosensitive drug delivery systems24
Nanoparticles of ZnO/Berberine complex contract COVID-19 and respiratory co-bacterial infection in addition to elimination of hydroxychloroquine toxicity22
Recent progress in drying technologies for improving the stability and delivery efficiency of biopharmaceuticals21
Pharmaceutical application and development of fixed-dose combination: dosage form review20
Development of oral aprepitant-loaded chitosan–polyethylene glycol-coated cyclodextrin nanocapsules: formulation, characterization, and pharmacokinetic evaluation19
Selenium nanostructure: Progress towards green synthesis and functionalization for biomedicine19
Quality by Design (QbD) application for the pharmaceutical development process18
Current perspectives of artificial oxygen carriers as red blood cell substitutes: a review of old to cutting-edge technologies using in vitro and in vivo assessments18
Development of immunotherapy and nanoparticles-based strategies for the treatment of Parkinson’s disease18
A comprehensive review on different approaches for tumor targeting using nanocarriers and recent developments with special focus on multifunctional approaches17
Recent studies on modulating hyaluronic acid-based hydrogels for controlled drug delivery17
Iron oxide nanoparticles-loaded hydrogels for effective topical photothermal treatment of skin cancer17
Development of a zero-order kinetics drug release floating tablet with anti–flip-up design fabricated by 3D-printing technique17
Recent advances in nano/microparticle-based oral vaccines17
Three-Dimensional Printing for Oral Pharmaceutical Dosage Forms16
Thermosensitive nasal in situ gelling systems of rufinamide formulated using modified tamarind seed xyloglucan for direct nose-to-brain delivery: design, physical characterization, and in vivo evaluat15
Exemestane encapsulated copolymers L121/F127/GL44 based mixed micelles: solubility enhancement and in vitro cytotoxicity evaluation using MCF-7 breast cancer cells15
Micronization of a poorly water-soluble drug, fenofibrate, via supercritical-fluid-assisted spray-drying15
Effects of lipid nanoparticles on physicochemical properties, cellular uptake, and lymphatic uptake of 6-methoxflavone15
pH-sensitive beads containing curcumin loaded nanostructured lipid carriers for a colon targeted oral delivery system14
Active targeting via ligand-anchored pH-responsive strontium nanoparticles for efficient nucleic acid delivery into breast cancer cells14
A quality by design approach in oral extended release drug delivery systems: where we are and where we are going?14
Microneedle systems for delivering nucleic acid drugs14
Tumor spheroid-based microtumor models for preclinical evaluation of anticancer nanomedicines14
Progress and recent trends in photodynamic therapy with nanoparticles13
Ameliorative potential of Sterculia tragacantha aqueous extract on renal gene expression and biochemical parameters in streptozotocin-induced diabetic rats13
Microemulsion as a promising carrier for nose to brain delivery: journey since last decade13
Ophthalmic dosage forms for drug delivery to posterior segment12
Anti-inflammatory effects of a topical emulsion containing Helianthus annuus oil, glycerin, and vitamin B3 in mice12
A comparative evaluation of anti-tumor activity following oral and intravenous delivery of doxorubicin in a xenograft model of breast tumor12
Ultra deformable vesicles for boosting transdermal delivery of 2-arylpropionic acid class drug for management of musculoskeletal pain12
Graphene-based nanomaterial system: a boon in the era of smart nanocarriers11
Quality by design approach to the development of transdermal patch systems and regulatory perspective11
Statistical design of experiment-based formulation development and optimization of 3D printed oral controlled release drug delivery with multi target product profile10
Erythromycin dermal delivery by MoS2 nanoflakes10
Alginate-coated chitosan nanoparticles protect protein drugs from acid degradation in gastric media10
Population pharmacokinetic analysis of lornoxicam in healthy Korean males considering creatinine clearance and CYP2C9 genetic polymorphism10
Potential therapeutic and pharmacological strategies for SARS-CoV210
0.045466899871826